Clinical Trial Update: Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

View source ↗

Summary

Post-marketing safety study of Boostrix vaccine has completed and summarizes safety monitoring for diphtheria, tetanus, and pertussis indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Tetanus | Status: COMPLETED